Surgical Bleeding

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

EMA withdrawal · 2018-10-10
EMA Withdrawn: Raplixa (human fibrinogen;human thrombin) — Mallinckrodt Pharmaceuticals Ireland Limited
Raplixa, a human fibrinogen and human thrombin product, has been withdrawn from the market by Mallinckrodt Pharmaceuticals Ireland Limited.